“The Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau released its bi-annual Ryan White HIV/AIDS Program Highlights. The Philadelphia Department of Public Health’s “C Ya!” project, which aimed to reduce disparities related to HCV co-infection among people with HIV, was the main project highlighted in the publication! More than 45,000 Read more…
“We believe Philadelphia can be the first city to eliminate Hep C – I believe that to my core. We need to be voting, we need to be asking our local government officials to provide resources.” ~Stacey Trooskin This was just one of the powerful statements Stacey Trooskin Read more…
Former Black Panther and internationally renowned journalist Mumia Abu-Jamal spent 5 years fighting for access to hepatitis C treatment while in prison. On July 19, a federal appeals court upheld his right to sue Corrections Department employees for denying him access to life-saving medications. Read more about the case here. Read more…
“On World Hepatitis Day, we’re calling for bold political leadership, with investments to match. We call on all countries to integrate services for hepatitis into benefit packages as part of their journey towards universal health coverage.” WHO Director -General Dr. Tedros Adhanom Ghebreyesus On World Hepatitis Day, the World Health Read more…
Washington, DC – Today, the House of Representatives passed two amendments that would provide $20 million in additional funding to programs that will prevent new cases of HIV and viral hepatitis stemming from the nation’s opioid epidemic and improve HIV prevention and care services in minority communities. As part of its Read more…
Pennsylvania officials declared an outbreak of hepatitis A in the state on Monday, citing 171 cases that have been reported since January 2018 in 36 counties, including Philadelphia. The declaration makes Pennsylvania eligible for federal funds to purchase additional doses of a vaccine against the liver disease, whose symptoms can Read more…
The House Appropriations Committee has released its budget proposal for the fiscal year 2020, affecting viral hepatitis through increased funding and awareness. View the full report here and the excerpted portions below. Infectious Diseases and the Opioid Epidemic.—The Committee includes an increase of $15,000,000 to strengthen efforts to conduct surveillance Read more…
View the April 30 press release from the FDA here. The U.S. Food and Drug Administration approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously approved to treat HCV in adults in 2017. “Direct-acting Read more…
Although 124 countries now have national plans for viral hepatitis elimination, 42% of plans have no domestic funding. The United States lags behind in this estimation of the year countries will achieve the World Health Organization elimination target. From Infohep: Most countries will struggle to eliminate hepatitis C by 2030 Read more…
The state of Washington said Friday it has selected AbbVie to provide hepatitis C medication through an unconventional subscription payment program that seeks to expand patient access while containing drug costs. The contract is part of the state’s plan to eliminate the common viral infection by 2030. “Last year, I committed Washington to Read more…